A long-lasting third complete remission after second autologous transplant followed by maintenance treatment with rituximab in a patient with diffuse large cell non-Hodgkin's lymphoma

Am J Hematol. 2006 Dec;81(12):986-7. doi: 10.1002/ajh.20636.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / prevention & control*
  • Male
  • Middle Aged
  • Neoplastic Stem Cells / transplantation
  • Prednisone / administration & dosage
  • Remission Induction
  • Rituximab
  • Secondary Prevention
  • Stem Cell Transplantation* / adverse effects
  • Transplantation, Autologous
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol, modified